MedTrace Logo

Penn State TXT2Quit Study

NCT02367391 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2017-06-15

Study results available
· View outcomes & findings →

Summary

This study is evaluating the feasibility and short term smoking cessation outcomes of an automated smoking cessation intervention delivered via mobile phone text messaging as an adjunct to Varenicline in a primary care setting.

Conditions

  • Nicotine Dependence, Cigarettes

Interventions

BEHAVIORAL

Motivational Text Messages

Usual care plus motivational text messages sent via Mobile Phone. All participants receive the active medication, Varenicline.

BEHAVIORAL

Control

Usual Care. All participants receive the active medication, Varenicline.

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02367391 on ClinicalTrials.gov